ISO 11607

What is ISO 11607?

ISO 11607 is a two-part international standard for packaging terminally sterilized medical devices. ISO 11607-1:2019 addresses materials, preformed sterile barrier systems, sterile barrier systems, and packaging systems intended to maintain sterility until the point of use.

ISO 11607-2:2019 addresses development and validation of packaging processes, including forming, sealing, and assembly. Manufacturers usually need to consider both parts rather than treating packaging material selection and process validation as separate compliance projects.

What are the current editions of ISO 11607-1 and ISO 11607-2?

Both base standards remain the 2019 editions and were confirmed as current in 2024. Part 1 has Amendment 1:2023, and Part 2 has Amendment 1:2023; both concern the application of risk management. A current compliance reference should therefore identify the applicable 2019 part together with its 2023 amendment.

ISO is also developing an additional Part 3. Until it is published, an under-development draft should not be presented as a current International Standard.

What is a sterile barrier system?

A sterile barrier system is the minimum package that minimizes the risk of microbial ingress and allows aseptic presentation of the sterile contents at the point of use. A broader packaging system may add protective packaging needed to withstand storage, handling, and distribution.

ISO 11607 does not assume that a package is suitable merely because it can be sealed. Material compatibility, package integrity, opening characteristics, sterilization exposure, distribution stresses, and shelf-life claims all need appropriate evidence.

What packaging processes need validation?

Processes used to form, seal, or assemble the sterile barrier system require controlled development and validation. The manufacturer should establish critical process parameters and acceptance criteria, qualify the relevant equipment and process, and maintain evidence that routine production remains within validated conditions.

These activities should connect with the device manufacturer’s quality system and regulatory dossier. They can form part of evidence prepared for EU MDR market access or a U.S. medical device submission.

Does ISO 11607 apply to every sterile medical device package?

Its principal scope is packaging for terminally sterilized medical devices. It does not cover every requirement for devices manufactured aseptically, and drug-device combination products may need additional packaging controls. Manufacturers should begin with the product, sterilization method, intended shelf life, distribution environment, and target-market requirements before defining the validation program.